enGene,Inc.,a gene therapy company focused on development of therapeutics using its proprietary “Gene Pill” and enema gene delivery platform, today announced the appointment of Dr. Dennis H. Langer to its Board of Directors.
enGene,Inc.,a gene therapy company focused on development of therapeutics using its proprietary “Gene Pill” and enema gene delivery platform, today announced the appointment of Dr. Dennis H. Langer to its Board of Directors.